|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.08 USD | -2.52% |
|
-4.44% | +6.68% |
| 06-18 | Swiss trade surplus at CHF 6.11 bln in May | RE |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| Market Cap | 268B 234B 216B 203B 379B 25,291B 383B 2,567B 995B 12,451B 1,007B 985B 43,251B | P/E 2026 * |
20.3x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 300B 262B 242B 227B 425B 28,334B 429B 2,876B 1,115B 13,949B 1,128B 1,103B 48,454B | EV / Sales 2026 * |
5.27x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.05% | Yield 2027 * | 3.14% |
Last Transcript: Novartis AG
| 1 day | -2.52% | ||
| 1 week | -4.44% | ||
| Current month | -2.06% | ||
| 1 month | -1.39% | ||
| 3 months | -1.82% | ||
| 6 months | +8.73% | ||
| Current year | +6.68% |
| 1 week | 146.92 |  | 153.32 |
| 1 month | 142.26 | | 154.71 |
| Current year | 135.55 | | 170.46 |
| 1 year | 112.34 | | 170.46 |
| 3 years | 92.19 | | 170.46 |
| 5 years | 74.09 | | 170.46 |
| 10 years | 66.93 | | 170.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.52% | -4.44% | - | - | 269B | |
| -1.21% | -5.37% | +39.94% | +145.38% | 980B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 317B | |
| +0.61% | -2.53% | +25.46% | +12.27% | 270B | |
| +4.59% | +3.68% | -39.28% | -46.92% | 191B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| -2.74% | -3.67% | +5.57% | -37.07% | 144B | |
| Average | -0.96% | -2.77% | +17.44% | +32.15% | 352.08B | |
| Weighted average by Cap. | -1.22% | -3.43% | +27.61% | +62.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.02B 49.72B 45.98B 43.09B 80.67B 5,377B 81.33B 546B 212B 2,647B 214B 209B 9,196B | 60.42B 52.69B 48.73B 45.67B 85.49B 5,699B 86.19B 579B 224B 2,805B 227B 222B 9,745B |
| Net income | 14.15B 12.34B 11.41B 10.69B 20.02B 1,334B 20.18B 135B 52.49B 657B 53.1B 51.96B 2,282B | 15.67B 13.67B 12.64B 11.84B 22.17B 1,478B 22.35B 150B 58.14B 728B 58.82B 57.56B 2,528B |
| Net Debt | 32.26B 28.13B 26.01B 24.38B 45.64B 3,042B 46.01B 309B 120B 1,498B 121B 118B 5,203B | 28.3B 24.68B 22.82B 21.39B 40.04B 2,669B 40.36B 271B 105B 1,314B 106B 104B 4,564B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 147.08 $ | -2.52% | 1,869,631 |
| 26-06-17 | 150.88 $ | -0.03% | 1,664,884 |
| 26-06-16 | 150.93 $ | -0.42% | 1,589,302 |
| 26-06-15 | 151.56 $ | -0.99% | 1,683,510 |
| 26-06-12 | 153.07 $ | -0.55% | 1,178,040 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
Select your edition
All financial news and data tailored to specific country editions
